The global chronic hepatitis B treatment market is experiencing significant growth. This trend can be attributed to a growing of factors, including an elevating population, advanced diagnostic capabilities, and rising awareness about the disease. The market is in addition driven by developments in treatment approaches, such as antiviral therapies.